Sept 17 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON PRELIMINARY RESULTS OF COMPANY'S ATL1102 FOR DMD PHASE II CLINICAL TRIAL.
Sept 17 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON PRELIMINARY RESULTS OF COMPANY'S ATL1102 FOR DMD PHASE II CLINICAL TRIAL.